Sign in
4

Changes in Ownership

Beta Bionics, Inc. Filed Acc 0001415889-25-006232

Chief Product Officer acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mensinger Mike Chief Product Officer 2025-02-27 Grant or award +35,000 94,019 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mensinger Mike Chief Product Officer 2025-02-27 Grant or award · Employee Stock Option (right to buy) +52,000 52,000 D: show line 2 in the form
Loading xslF345X05/form4-03032025_050306.xml…